Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

NCT00916409 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

700

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

DEVICE: NovoTTF-100A device
DRUG: Temozolomide

Sponsor

NovoCure Ltd.